Lecault Veronique 4
4 · AbCellera Biologics Inc. · Filed Jun 24, 2024
Insider Transaction Report
Form 4
Lecault Veronique
DirectorChief Technology Officer
Transactions
- Exercise/Conversion
Common Shares
2024-06-21$0.19/sh+83,334$15,667→ 2,123,456 total - Exercise/Conversion
Share option (right to buy)
2024-06-21−83,334→ 3,829,771 totalExercise: $0.19Exp: 2027-03-23→ Common Shares (83,334 underlying)
Holdings
- 273,630(indirect: See Footnote)
Common Shares
- 61,580(indirect: By Spouse)
Common Shares
- 7,155,008(indirect: See Footnote)
Common Shares
Footnotes (3)
- [F1]These shares are held by Pacific Swell Capital Corp ("Pacific Swell"). The Reporting Person is a director of Pacific Swell and shares voting and dispositive power with respect to the shares held by Pacific Swell. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
- [F2]These shares are held by Slomo Family Trust. The Reporting Person is a co-trustee of the Slomo Family Trust. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of her indirect pecuniary interest therein.
- [F3]The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date.